Molecular characterization of Gla-rich protein (GRP) gene expression and function

Gla-rich protein (GRP) is a vitamin K-dependent protein related to bone and cartilage recently described. This protein is characterized by a large number of Gla (γ-carboxyglutamic acid) residues being the protein with the highest Gla content of any known protein. It was found in a widely variety of tissues but highest levels was found in skeletal and cartilaginous tissues. This small secreted protein was also expressed and accumulated in soft tissues and it was clearly associated with calcification pathologies in the same tissues. Although the biological importance of GRP remains to be elucidated, it was suggested a physiological role in cartilage development and calcification process during vertebrate skeleton formation. Using zebrafish, an accepted model to study skeletal development, we have described two grp paralog genes, grp1 and grp2, which exhibited distinct patterns of expression, suggesting different regulatory pathways for each gene. Gene synteny analysis showed that grp2 gene is more closely related to tetrapod grp, although grp1 gene was proposed to be the vertebrate ortholog by sequence comparison. In addition, we identified a functional promoter of grp2 gene and using a functional approach we confirmed the involvement of transcription factors from Sox family (Sox9b and Sox10) in the regulation of grp2 expression. In an effort to provide more information about the function of grp isoforms, we generated two zebrafish transgenic lines capable to overexpress conditionally grp genes and possible roles in the skeleton development were studied. To better understand GRP function a mammalian system was used and the analysis of knockout mice showed that GRP is involved in chondrocyte maturation and the absence of GRP is associated to proteoglycans loss in calcified articular cartilage. In addition, we detected differences in chondrogenesis markers in articular chondrocyte primary culture. Overall, our data suggest a main role for GRP on chondrocyte differentiation.

Recovery of gold(0) nanoparticles from aqueous solutions using effluents from a bioremediation process

The use of biological processes with the aim of the recovery of gold from low-concentration solutions derived from leaching of secondary sources is gaining increasing importance owing to the scarcity of the primary resources and the economic and environmental advantages usually presented by these methods. Thus, the addition in batch and continuous processes of different solutions containing biogenic sulphide, which was generated by the activity of sulphate-reducing bacteria (SRB), to gold(III) solutions was investigated for that purpose. In the batch experiments, AuS nanoparticles with sizes of between 6 and 14 nm were obtained (corresponding to 100% removal of Au(III) from solution) if the biogenic sulphide was generated in a typical nutrient medium for SRB, whereas Au(0) nanoparticles with sizes of below 8 nm were obtained (corresponding to 62% removal of Au(III)) if effluent from a SRB bioremediation process for treating acid mine drainage (AMD) was used instead. These results stimulated the development of a continuous process of addition, in which two sulphide-rich effluents, which resulted from a SRB bioremediation process for treating two types of AMD (from a uranium mine and a polysulphide mine), were tested. In both cases, Au(0) nanoparticles with sizes of between 6 and 15 nm were mainly obtained, and the percentage removal of Au(III) from solution ranged from 76% to 100%. The processes described allow the simultaneous treatment of AMD and recovery of metallic gold nanoparticles, which are a product with a wide range of applications (e.g., in medicine, optical devices and catalysis) and high economic value. The synthesis process described in this work can be considered as novel, because it is the first time, to our knowledge, that the use of effluent from a SRB bioremediation process has been reported for the recovery of gold(III) as gold(0) nanoparticles.